Cargando…
ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism
C-type natriuretic peptide (CNP) and its receptor natriuretic peptide receptor B (NPR-B) are physiological potent positive regulators of endochondral bone growth; therefore, the CNP/NPR-B signaling pathway is one of the most promising therapeutic targets for treating growth failure and dwarfism. In...
Autores principales: | Morozumi, Naomi, Yotsumoto, Takafumi, Yamaki, Akira, Yoshikiyo, Kazunori, Yoshida, Sayaka, Nakamura, Ryuichi, Jindo, Toshimasa, Furuya, Mayumi, Maeda, Hiroaki, Minamitake, Yoshiharu, Kangawa, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386482/ https://www.ncbi.nlm.nih.gov/pubmed/30794654 http://dx.doi.org/10.1371/journal.pone.0212680 |
Ejemplares similares
-
Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity
por: Yotsumoto, Takafumi, et al.
Publicado: (2019) -
Foramen magnum stenosis and midface hypoplasia in C-type natriuretic peptide-deficient rats and restoration by the administration of human C-type natriuretic peptide with 53 amino acids
por: Yotsumoto, Takafumi, et al.
Publicado: (2019) -
Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats
por: Hirota, Keisho, et al.
Publicado: (2018) -
Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death
por: Fujii, Toshihito, et al.
Publicado: (2018) -
Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria
por: Potluri, Vijay, et al.
Publicado: (2020)